North American Cannabis Consumers Are Leading Healthy, Engaged Lives

Results from the third annual Cannabis Culture Poll show that cannabis consumers in both the U.S. and Canada are mindful of their physical and mental health; they exercise and socialize more than the general population, and they have coping strategies for dealing with increased stress levels. New this year, the poll also indicates more public awareness is required around cannabis use and impaired driving.

The poll, commissioned by premier digital media and lifestyle brand Civilized in partnership with full-service research insights agency PSB Research, surveyed 1,604 adults from coast to coast in the U.S. and Canada. The online interviews explored views on cannabis, cannabis usage, and habits and behaviors of both consumers and non-consumers to better understand the lifestyle of modern cannabis consumers.

In the U.S., 73 per cent of cannabis consumers exercise at least once a week compared to 70 per cent of the American general population. Three in four Canadian consumers exercise at least once a week compared to 69 per cent of the Canadian general population. Consumers in both countries are increasingly turning to cannabis to deal with stress, with more Canadian consumers reporting stressful lives this year. Stress management techniques that consumers are using include talking to someone, relaxing or meditating and exercising. 
As legalization becomes a reality in Canada and in more American states, increased public education is needed with regard to impaired driving. In the U.S., significantly less than half (38 per cent) of American consumers believe cannabis impairs driving, in contrast with 58 per cent of the American general population. In Canada, only one-half of Canadian cannabis consumers think cannabis impairs driving ability (52 per cent), as opposed to 72 per cent of the Canadian general population.

"The poll results show again this year that cannabis consumers in both countries are engaged and active, with balanced social lives," says Derek Riedle, Publisher of Civilized. "That said, there is a need for more public education about the effects of cannabis consumption on driving. This is critical given the changing legalization landscape across North America."

With approximately one in four Americans and Canadians consuming cannabis, support for legalization is strong among the general population. One-third of both Americans and Canadians say they support medical legalization, with a further one-half of Americans (50 per cent) and Canadians (45 per cent) saying they would approve of legalizing both medical and recreational use.

"The survey questions were kept consistent with last year so we could track changes over time," says Jason Boxt, executive vice-president of PSB Research. "The results again show strong support for cannabis legalization among the general North American population, with more people open to considering consuming cannabis this year. We also see a favorable disposition toward dispensaries, especially for Canadians, in terms of safety, cleanliness and the purveyance of high-quality, regulated products."

Jason’s colleague Scott Elder will be presenting the full Cannabis Culture Poll results at the inaugural World Cannabis Congress taking place June 10 to 12, 2018 in Saint John, New Brunswick, Canada. Elder will be among dozens of industry experts, top researchers, policy makers, and leaders from the fields of alcohol, gaming, public safety, mainstream media, and more.

Check out the rest of the Cannabis Culture Poll here.


Glaucoma often makes the list of acceptable conditions for treatment by medical marijuana in states where the substance has been legalized, but the cannabis compound CBD could actually worsen the condition. A recent study from Indiana University has found that consuming CBD—a non-psychoactive compound in cannabis often used for medicinal purposes— actually increases eye pressure. "This study raises important questions about the relationship between the primary ingredients in cannabis and their effect on the eye," lead researcher Alex Straiker told Science Alert.